Qingdao Saber Technology Pharma QST
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Qingdao Saber Technology Pharma QST between 3 Jun 2025 and 9 Jun 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Qingdao Saber Technology Pharma QST
Retatrutide
Tested 2 Samples
Last test 9 Jun 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qingdao Saber Technology Pharma QST
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
9 Jun 2025
First
3 Jun 2025